GE launches temperature controlled processing tech for CAR T-cell therapy – BioPharma-Reporter.com
BioPharma-Reporter.com |
GE launches temperature controlled processing tech for CAR T-cell therapy
BioPharma-Reporter.com The technology can be applied to any type of cellular therapy, including chimeric antigen receptor (CAR) T-cell therapy. “A new software application called PremierCell enables upstream processing and at the same time, an improved version of the … |
